Prescriptions of a decades-old drug jumped among children after it was promoted as an autism treatment at a federal press conference. A Michigan Medicine study tracked what happened next, raising questions about how quickly public messaging can shape treatment decisions.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.